Wangbin Zhou

Stock Analyst at Citi

(3.65)
# 1,973
Out of 4,579 analysts
20
Total ratings
35.3%
Success rate
21.1%
Average return

Stocks Rated by Wangbin Zhou

Ascletis Pharma Inc.
Feb 3, 2026
Reiterated: Buy
Price Target: $32.00
Current: $8.85
Upside: +261.58%
Innovent Biologics, Inc.
Aug 28, 2025
Maintained: Buy
Price Target: $105.00$110.00
Current: $88.90
Upside: +23.73%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 20, 2025
Maintained: Buy
Price Target: $560.00
Current: $503.50
Upside: +11.22%
HUTCHMED (China) Limited
Aug 11, 2025
Maintained: Buy
Price Target: $42.00$36.00
Current: $17.48
Upside: +105.95%
3SBio Inc.
Jul 28, 2025
Maintained: Buy
Price Target: $21.00$36.00
Current: $16.93
Upside: n/a
Akeso, Inc.
Jul 28, 2025
Maintained: Buy
Price Target: $98.00$185.00
Current: $95.40
Upside: n/a
Shanghai Junshi Biosciences Co., Ltd.
Jul 28, 2025
Maintained: Buy
Price Target: $32.00
Current: $18.45
Upside: n/a
Antengene Corporation Limited
Jun 27, 2025
Downgraded: Hold
Price Target: $3.50
Current: $4.26
Upside: n/a
RemeGen Co., Ltd.
Mar 31, 2025
Maintained: Buy
Price Target: $32.00
Current: $84.20
Upside: n/a
Legend Biotech
Mar 12, 2025
Maintained: Buy
Price Target: $95
Current: $19.27
Upside: n/a
Maintained: Hold
Price Target: $25.00$40.00
Current: $24.70
Upside: n/a
Maintained: Buy
Price Target: $60.00
Current: $78.55
Upside: n/a
Maintained: Buy
Price Target: $52.00
Current: $34.82
Upside: n/a